华人健康
(301408)
| 流通市值：21.97亿 | | | 总市值：58.92亿 |
| 流通股本：1.49亿 | | | 总股本：4.00亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,892,464,110.99 | 2,503,904,455.17 | 1,266,847,107 | 4,531,692,295.23 |
| 营业收入 | 3,892,464,110.99 | 2,503,904,455.17 | 1,266,847,107 | 4,531,692,295.23 |
| 二、营业总成本 | 3,664,095,124.7 | 2,350,978,616.8 | 1,175,205,083.11 | 4,323,588,684.51 |
| 营业成本 | 2,597,540,141.1 | 1,667,169,353.41 | 841,486,683.18 | 3,053,593,919.21 |
| 利息支出 | - | - | - | 0 |
| 手续费及佣金支出 | - | - | - | 0 |
| 退保金 | - | - | - | 0 |
| 赔付支出净额 | - | - | - | 0 |
| 提取保险合同准备金净额 | - | - | - | 0 |
| 保单红利支出 | - | - | - | 0 |
| 分保费用 | - | - | - | 0 |
| 税金及附加 | 17,143,139.45 | 10,629,359.88 | 5,081,878.39 | 23,751,912.77 |
| 销售费用 | 843,204,258.08 | 538,543,586.27 | 261,295,611.45 | 997,770,391.32 |
| 管理费用 | 164,985,058.11 | 111,357,140.34 | 56,332,622.12 | 194,391,170.65 |
| 研发费用 | 22,553,167.86 | 12,859,028.94 | 6,522,397.24 | 29,387,268.49 |
| 财务费用 | 18,669,360.1 | 10,420,147.96 | 4,485,890.73 | 24,694,022.07 |
| 其中:利息费用 | 10,085,635.95 | 5,298,955.44 | 3,593,556.23 | 14,517,322.94 |
| 其中:利息收入 | 4,767,351.1 | 6,165,679.95 | 3,658,147.35 | 15,558,356.44 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 0 | 0 | - | 0 |
| 加:投资收益 | 4,548,916.76 | 3,072,405.24 | 348,798.93 | 1,618,812.17 |
| 净敞口套期收益 | - | 0 | - | - |
| 汇兑收益 | - | 0 | - | 0 |
| 资产处置收益 | 2,803,044.01 | 1,992,603.72 | 915,251.57 | 2,718,324.01 |
| 资产减值损失(新) | -11,940,804.15 | -8,592,627.82 | -8,480,253.97 | -27,487,722.98 |
| 信用减值损失(新) | -7,193,622.6 | -5,208,929.19 | -2,789,737.53 | -1,000,929.87 |
| 其他收益 | 9,507,277.39 | 6,176,240.89 | 2,747,921.99 | 23,972,667.36 |
| 四、营业利润 | 226,093,797.7 | 150,365,531.21 | 84,384,004.88 | 207,924,761.41 |
| 加:营业外收入 | 806,137.36 | 378,817.81 | 223,386.74 | 1,022,213.64 |
| 减:营业外支出 | 4,549,202.26 | 3,230,290.8 | 1,050,271.83 | 3,475,909.38 |
| 五、利润总额 | 222,350,732.8 | 147,514,058.22 | 83,557,119.79 | 205,471,065.67 |
| 减:所得税费用 | 50,958,876.99 | 35,828,990.89 | 18,473,171.52 | 53,211,960.36 |
| 六、净利润 | 171,391,855.81 | 111,685,067.33 | 65,083,948.27 | 152,259,105.31 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 171,391,855.81 | 111,685,067.33 | 65,083,948.27 | 152,259,105.31 |
| 终止经营净利润 | - | - | - | 0 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 156,726,575.76 | 103,743,088.72 | 61,222,277.52 | 137,699,528.81 |
| 少数股东损益 | 14,665,280.05 | 7,941,978.61 | 3,861,670.75 | 14,559,576.5 |
| 扣除非经常损益后的净利润 | 151,327,450.13 | 100,810,067.04 | 59,702,002.89 | 129,048,863.19 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.39 | 0.26 | 0.15 | 0.34 |
| (二)稀释每股收益 | 0.39 | 0.26 | 0.15 | 0.34 |
| 八、其他综合收益 | 1,563,598.63 | 1,563,598.63 | - | 334,330 |
| 归属于母公司股东的其他综合收益 | 1,563,598.63 | 1,563,598.63 | - | 334,330 |
| 九、综合收益总额 | 172,955,454.44 | 113,248,665.96 | 65,083,948.27 | 152,593,435.31 |
| 归属于母公司股东的综合收益总额 | 158,290,174.39 | 105,306,687.35 | 61,222,277.52 | 138,033,858.81 |
| 归属于少数股东的综合收益总额 | 14,665,280.05 | 7,941,978.61 | 3,861,670.75 | 14,559,576.5 |
| 公告日期 | 2025-10-25 | 2025-08-27 | 2025-04-29 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |